Emily L. Lowe, Ph.D.
Affiliations: | 2010 | University of California, Los Angeles, Los Angeles, CA |
Area:
Immunology, OncologyGoogle:
"Emily Lowe"Parents
Sign in to add mentor| Genhong Cheng | grad student | 2010 | UCLA | |
| (Toll-Like Receptor 2 is Protective in a Mouse Model of Colitis-associated Colorectal Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burke BP, Levin BR, Zhang J, et al. (2015) Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Molecular Therapy. Nucleic Acids. 4: e236 |
| Ringpis GE, Shimizu S, Arokium H, et al. (2012) Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. Plos One. 7: e53492 |
| Lowe EL, Crother TR, Rabizadeh S, et al. (2010) Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. Plos One. 5: e13027 |